Contact this trialFirst, we need to learn more about you.
Antiretroviral Therapy
bictegravir/emtricitabine/tenofovir alafenamide +1 More for Nonadherence
Recruiting3 awardsPhase 4
Columbia, Missouri
This trial aims to see if the ACCELERATE model of care is effective in achieving HIV viral suppression at Week 24. The study will also look into whether this model is acceptable, appropriate, feasible
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.